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Abstract
Background: Microarray technology has become popular for gene expression profiling, and many
analysis tools have been developed for data interpretation. Most of these tools require complete
data, but measurement values are often missing A way to overcome the problem of incomplete
data is to impute the missing data before analysis. Many imputation methods have been suggested,
some naïve and other more sophisticated taking into account correlation in data. However, these
methods are binary in the sense that each spot is considered either missing or present. Hence, they
are depending on a cutoff separating poor spots from good spots. We suggest a different approach
in which a continuous spot quality weight is built into the imputation methods, allowing for smooth
imputations of all spots to larger or lesser degree.
Results:  We assessed several imputation methods on three data sets containing replicate
measurements, and found that weighted methods performed better than non-weighted methods.
Of the compared methods, best performance and robustness were achieved with the weighted
nearest neighbours method (WeNNI), in which both spot quality and correlations between genes
were included in the imputation.
Conclusion: Including a measure of spot quality improves the accuracy of the missing value
imputation. WeNNI, the proposed method is more accurate and less sensitive to parameters than
the widely used kNNimpute and LSimpute algorithms.
Background
During the last decade microarray technology has become
an increasingly popular tool for gene expression profiling.
Microarrays have been used in numerous biological con-
texts from studies of differentially expressed genes in
tumours [1-4] to identification of cell cycle regulated
genes in yeast [5]. A theme in microarray investigations is
that they generate large amounts of data, and computer-
based visualization and analysis tools must be used in
experiment analysis. Tools such as hierarchical clustering
[6], multidimensional scaling [7], and principal compo-
nent analysis [8] are frequently used to visualize data.
Machine learning methods like support vector machines
[9] and artificial neural networks [10] have been used suc-
cessfully to classify tumor samples. Common for these
methods is that they in their standard versions assume
complete data sets.
However, data is usually not complete. Data values may
be missing due to poor printing of the arrays and conse-
quently marked as missing during image analysis, but
more common is that values are marked to be missing in
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a quality filtering pre-processing step. Common filter cri-
teria are to mark spots with small area, spots with noisy
background, spots with low intensity, or combinations of
these [11]. One strategy to keep data complete is to
remove reporters having missing values, but this may lead
to an unnecessarily large loss of data. In particular when
working with large data sets, reporters rarely have a com-
plete set of values over all experiments. Another strategy is
to keep reporters with not too many missing values and
modify the subsequent analysis to handle incomplete
data. However, it may not be feasible to modify the anal-
ysis tool, and therefore a popular approach is to impute
the missing data in an intermediate step before analysis.
A common method to impute missing values is to replace
missing values with the reporter average, i.e., the average
WeNNI is the most accurate imputation method Figure 1
WeNNI is the most accurate imputation method. Performance of the five imputation methods with varying β. As 
explained in the Methods section, larger β changes weights to smaller values. In non-weighted methods β is the SNR cutoff. 
The increase in MSD for large β is an effect from too many missing values, which implies imputation breaks down. The standard 
error of means are within the line thicknesses. (A) Breast cancer data. WeNNI (black line) has the lowest MSD and the 
weighted methods perform better than the non-weighted methods. All methods have a minimum MSD around β = 0.2. (B) 
Melanoma data. WeNNI (black line) has the lowest MSD and the weighted methods perform better than the non-weighted 
methods. All methods have a minimum MSD around β = 0.6. (C) Mycorrhiza data. WeNNI (black line) retains the lowest MSD, 
whereas KNNimpute (red line) performs better that the weighted reporter average method. This may be explained as an 
effect of a different experimental design as discussed in the text. The minimum MSD is found in a β range 0.3–1 for the differ-
ent methods.
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for the particular reporter over all experiments. Troyan-
skaya et al. showed that this method is not sufficient as it
neglects correlations in data [12]. They also suggested a
method KNNimpute, that was shown to reconstruct miss-
ing values well. In KNNimpute, for each reporter the most
similar reporters are found and the weighted average of
these reporters is used as the imputation value. Other
imputation methods have been suggested [13-18] using
the same basic idea that the imputation value is taken as
an average over the neighbouring reporters.
As far as we know, all suggested imputation methods are
binary in the sense that each spot is considered either
missing or present. Hence they depend on a cutoff, e.g., in
intensity, separating poor spots from good spots. Tuning
this cutoff is a balance act – a too liberal cutoff means
WeNNI is most accurate over all ranges of spot quality Figure 2
WeNNI is most accurate over all ranges of spot quality. The contribution to MSD for specific SNR for the different 
imputation methods applied to the three different data sets using β = 0.3. These plots were created using a sliding window con-
taining 1% of all spots. Spots with small SNR (low quality) have the largest impact on MSD. (A) In the breast cancer data a 
weighted scheme is clearly essential and WeNNI is most accurate over all ranges of SNR (B) In the melanoma data a weighted 
scheme is clearly essential and the weighted reporter average show best performance for an SNR range 0.2–1. (C) In the myc-
orrhiza data the breakdown of the average reporter methods is very prominent. For the SNR range 0.07–0.4 it is even better to 
use no impute (green line) than the average methods. The breakdown of the reporter average methods are discussed in the 
text.
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noisy spots are kept in data, which may complicate subse-
quent analysis. On the other hand being too strict means
spots containing information are marked as missing val-
ues and information is thrown away.
We suggest a more balanced approach, in which a spot
quality weight is built into the imputation methods: good
quality spots have more impact on the imputation of
other spots, and are themselves subject to less imputation
than spots with poorer quality. To examine the effects of
this approach we extended two widely used methods,
average imputation and KNNimpute [12], to handle con-
tinuous weights. We applied the two resulting methods to
three data sets containing replicate measurements and
found that weighted methods perform better that non-
weighted.
Results and discussion
As outlined in the Methods section, we devised two impu-
tation methods using spot quality weights. These methods
are generalizations of two non-weight based methods and
we evaluated the methods with replicate data sets. We
used the mean squared deviation (MSD) to compare the
performance of the two suggested methods, their non-
weighted counterparts, and LSimpute [17]. We did the
comparisons varying the spot quality threshold for miss-
ing values for the non-weight based methods. Corre-
spondingly, for the weighted methods we varied the
weight tuning parameter β  in the calculations of the
weights (see Methods).
In Figure 1 we present how the performance varied with a
changing β in the three data sets. The plots show that
WeNNI has the lowest MSD for all three data sets, the
weighted methods outperform their non-weighted coun-
terparts, and the minimum MSD is within the β range
0.1–1 for all methods.
The overall MSD is larger for the melanoma data set com-
pared to the two other data sets, which may be due to that
the melanoma data was generated a few years earlier than
the other data.
An interesting finding was that weighted reporter average
outperformed KNNimpute and LSimpute in the breast
cancer and melanoma data sets. This result was unex-
pected since the weighted reporter average method
neglects correlations between reporters. Moreover, the
assumption for using reporter average is in general prob-
lematic, since the expression of a reporter in one experi-
mental condition does not always reflect the expression of
the reporter in another condition. For the mycorrhiza data
used here the situation is even worse, since the cyclic
experimental design [20] makes the expression value in
one experiment auti-correlated to the reporter's average
over the other experiments. For the nearest neighbours
imputation methods however this problem does not arise
because imputations are calculated as an average over the
same experiment. These results imply one should con-
sider the experimental design and choose imputation
method carefully.
For small β all methods showed approximately equal per-
formance. This result was expected, because for small β
most weights are close to unity. In consequence, only a
small fraction of the spots are imputed and make a minor
contribution to the MSD. Moreover, the weights are effec-
tively binary for small β, and the weighted methods
become identical to their non-weighted counterparts.
To examine the difference between the weighted methods
and their non-weighted counterparts, we plotted MSD as
a function of SNR (Figure 2). As expected, spots with small
SNR contributed most to MSD. The discrepancy between
mycorrhiza data and the other two data sets also showed
up here – the breakdown of the reporter average methods
in the mycorrhiza data is very prominent (Figure 2C). The
melanoma and breast cancer data showed very similar
patterns for the different methods and the weighted meth-
ods performed better than their counterparts for all SNR.
In some ranges of SNR, weighted reporter average even
surpassed WeNNI, but overall WeNNI imputed the values
most accurately.
In Figure 3, we demonstrate the effect of varying β for
WeNNI and KNNimpute using the breast cancer data. In
Comparison of WeNNI and KNNimpute Figure 3
Comparison of WeNNI and KNNimpute. MSD contri-
butions from specific SNR and different β for the breast can-
cer data set. This plot was created using a sliding window 
containing 1% of all spots.
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KNNimpute, only spots with smaller SNR than the cutoff
β are imputed, and consequently the performance for SNR
larger than β follows the no impute curve. For KNNim-
pute a choice of β = 0.3 was close to optimal. Using a
smaller β deteriorated the imputation in two ways. Spots
with SNR between the used β and the optimal value 0.3
were not imputed. In the plot we can see that the quality
of these spots is so bad that preferably they should be
imputed. More importantly, since these spots were not
considered missing they were used in the imputation of
values with very small SNR, which made the imputation
less accurate. Moreover, when we used a too large β, the
spots with SNR in the range 0.3–3 were imputed and their
deviation from the replicate became larger than if they
were not imputed. Also, the imputation of the spots with
very small SNR became worse, since less information was
used in the imputation. Choosing β corresponds to setting
a cutoff in quality control criteria, and Figure 3 illustrates
how a suboptimal cutoff level will lead to less reliable
data. For WeNNI the cutoff is smoothened by the usage of
continuous weights, and consequently WeNNI is more
robust with respect to β.
In Figure 4, we illustrate how the performance of WeNNI
and KNNimpute depends on the number of neighbours,
K, used in the imputation. We notice that both methods
are insensitive to changing K. For a small number of
neighbours, both methods are insufficient. Troyanskaya et
al. suggested K  to be in the range between 10 and 20
neighbours for KNNimpute [12]. Our results agree with
this finding and also show that the imputation of our data
sets was accurate for a larger number of nearest neigh-
bours.
When comparing non-weighted imputation methods, it is
natural to calculate the comparison measure over
imputed values only. Including non-imputed values in
the evaluation makes no sense, as these values are not
modified and thus independent of the imputation
method. This is also the way imputation methods are
compared in the literature [12-18]. However, for a
weighted method every expression value is modified, and
it is sensible to include all values in the calculation of
MSD. In Table 1 we compare LSimpute.
KNNimpute, and WeNNI using both MSD and
MSD_imputed. MSD_imputed is calculated as MSD but
over imputed values (as defined by binary methods) only.
We note that MSD_imputed is larger than MSD for all
methods and data sets, which is expected because
MSD_imputed is calculated over poor spots only and
poor spots are expected to deviate more from their dupli-
cates. Moreover, for MSD_imputed the difference between
the methods is more apparent, which is a consequence
from comparing poor spots only. In MSD all spots are
included in the comparison and as good quality spots are
modified to lesser degree, the difference between the
methods looks smaller. We note that WeNNI is the most
accurate method also using MSD_impute, in other words.
WeNNI has the best performance even when values not
imputed by non-weighted methods are excluded from the
comparison.
For the largest data set, breast cancer data with approxi-
mately 55000 spots, a typical WeNNI run takes approxi-
mately 10 CPU minutes on a off-the-shelf computer
(AMD Athlon 3700+ processor and 1 GB RAM), whereas
kNNI is twice as fast. These two algorithms are imple-
mented in the same C++ code base and differs only in the
calculation of the imputation values. A comparison with
LSimpute is not fair since LSimpute is an adaptive algo-
rithm and is implemented in Java.
Spot quality weights and expression value imputation
The starting point for imputing expression values in this
report is that the weight of a spot should depend on its
quality, as best estimated from data. Here, we used a
straight forward SNR based weight as it was not our aim
to study quality of spots. The SNR based quality weights
were introduced in [21], and many different studies of
quality measures have been described [11,26-28]. These
papers concentrate on studying how the quality of spots
should be defined.
Analyses in microarray projects are commonly based on
spot intensities, and for that reason we examined if using
WeNNI and KNNimpute are insensitive to number of neigh- bours used Figure 4
WeNNI and KNNimpute are insensitive to number 
of neighbours used. Performance of WeNNI and KNNim-
pute is plotted against the number of nearest neighbours for 
all three data sets using β = 1.
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intensities instead of SNR changes the findings in this
paper. We found that using this simpler quality weight
(Eq. 4), the performance was almost as good as when
using the SNR based weights (data not shown). The fact
that the imputed expression value on average gets closer
to its pristine replicate value, indicates that the SNR based
weight may be a slightly better estimate of the spot qual-
ity.
In imputation of expression values, as in any transforma-
tion of data (e.g., LOWESS normalisation or centralisa-
tion), one must be careful to not destroy the biological
signal in the data. In our three data sets, we noticed that
when WeNNI is used, the deviation from the pristine rep-
licate is on average smaller than when not doing the trans-
formation, in other world, on average an expression value
is closer to its replicate after the transformation. The effect
is measurable even for the naïve weight used here.
The goal of a weight is to catch the "true" quality of the
spot, and as such it is important to define spot quality
weight calculation to suit the data at hand, prior knowl-
edge, and expertise. One important aspect of applying
prior knowledge into weight calculation is that initial pre-
screening of array data should still be done before impu-
tation, or any subsequent analysis. In this screening step
bad spots are removed, and known malfunction in data
(arrays) should be communicated with zero weights.
Conclusion
Virtually every analysis of microarray data is preceded by
a filtering step, in which each spot is required to fulfil cer-
tain quality control criteria. If the spot fails to meet the
quality requirements it is marked as a missing value. This
is equivalent to accompanying each expression value with
a binary weight, and enforces an abrupt cutoff in quality
control criteria. We have generalised two widely used
imputation methods to use continuous weights. Our find-
ing that the weighted imputation methods outperformed
their non-weighted counterparts, suggests that using con-
tinuous weights is superior to using binary weights. Our
suggested improvement – to use continuous weights – is
generic in the sense that most imputation methods can be
generalised to use continuous weights.
The weighted nearest neighbours imputation method pre-
sented in this paper. WeNNI, outperformed all other
tested methods for the three different data sets used in this
study. WeNNI performs accurate imputation of expres-
sion values and is insensitive to the parameter values
used, i.e., the number of nearest neighbours and β. An
increasing β corresponds to having a more strict spot qual-
ity control criteria. For a non-weighted method it means
that more values are considered missing and consequently
imputed. Our results suggest that the usage of a continu-
ous weight makes the imputation less sensitive to the
choice of β. The findings in this manuscript are based on
comparisons of replicate data, however replicate data may
not be available in every experimental setting and the sci-
entific investigator cannot evaluate the impact of different
parameter values. The results in this study show that the
choice of parameters is not crucial, and suggest a value
around 10 for nearest, neighbours and a β in the range
0.1–1.
Methods
Data sets and pre-processing
To evaluate the imputation methods, we used three data
sets, i) Melanoma data. The melanoma data set was
obtained from a panel of 61 human cell lines [19]. For
each experiment, 19,200 reporters were printed in dupli-
cates. Identification of individual spots on scanned arrays
was done with ImaGene 4.0 (BioDiscovery, E1 Segundo,
CA, USA). ii) Breast cancer data. The breast cancer data set
is a subset of a larger ongoing study. We selected the 55
experiments that had been hybridised at the Swegene
DNA Microarray Resource Centre in Lund, Sweden, and
were from tumours mutated either in BRCA1 or in BRCA2.
Each array contained 55,488 spots and except a small
number of control spots each reporter was printed in
Table 1: Comparisons of WeNNI, KNNimpute, and LSimpute adaptive using two different measures. MSD is the mean squared 
deviation calculated over all spots, whereas MSD_imputed is calculated over spots with SNR smaller than β, i.e., the spots imputed in 
non-weighted methods. β was chosen to yield the lowest MSD for LSimpute adaptive. WeNNI is more accurate than LSimpute and 
KNNimpute, even though β was tuned to optimise the performance of LSimpute.
Data set Measure β WeNNI KNNimpute LSimpute adaptive
Breast cancer MSD 0.2 0.345 0.369 0.368
MSD_imputed 1.59 1.81 1.75
Melanoma MSD 0.6 0.995 1.08 1.05
MSD_imputed 3.41 3.77 3.64
Mycorrhiza MSD 0.2 0.216 0.241 0.244
MSD_imputed 0.840 0.902 0.954BMC Bioinformatics 2006, 7:306 http://www.biomedcentral.com/1471-2105/7/306
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duplicate. Identification of individual spots on scanned
arrays was done with GenePix Pro 4.0 (Axon Instruments,
Union City, CA, USA). iii) Mycorrhiza data. The mycor-
rhiza data set was generated to study ectomycorrhizal root
tissue [20]. In order to avoid any bias from using dye swap
replicates, we used half of the arrays from the study. We
used the 10 arrays denoted R3 between ECM's at different
time points, and R1 between ECM and REF (Figure 2 in
[20]). Each array contained 10,368 spots and except a
small number of control spots each reporter was printed
four times. Identification of individual spots on scanned
arrays was done with GenePix Pro 3.0.6.89) (Axon Instru-
ments, Union City, CA, USA).
For each spot, we used the mean spot intensity, Ifg, the
mean background intensity, Ibg, and the standard devia-
tion of the background intensity, σbg. For each spot we cal-
culated the signal-to-noise ratio (SNR) [11] as
Subscripts t and c denotes treatment and control, respec-
tively. As expression value, x, we used the logarithm to
base 2 of the ratio of the signal in the treatment sample
and the signal in the control sample
where spots with non-positive signal in either treatment
or control were marked as invalid.
We applied a liberal filter to the data. In the melanoma
data set we kept reporters having less than 50% invalid
values in both duplicates. The remaining data was split
into two replicate data sets. This was also done for the two
other data sets, with the exception that the mycorrhiza
data was split into four replicate data sets. Each data set
was then centralised experiment by experiment such that
the average expression value for an experiment was zero.
After filtering, the melanoma data consisted of two repli-
cate data sets each having 61 experiments and 17, 549
reporters, the breast cancer data consisted of two explicate
data sets each having 55 experiments and 23,764 report-
ers, and the mycorrhiza data consisted of four replicate
data sets each having 10 experiments and 2,052 reporters.
Quality weight
The basis for weight calculations are two weight formulae
inspired by previous work [21-24]. We used an SNR based
weight defined as
This weight is defined to be bound within zero and unity.
The free parameter β is used to tune the distribution of
weights. For a small β all weights are close to unity, except
when zero or negative intensities have been measured
which implies a zero weight. For a large β all weights are
close to zero. In non-weighted (binary) methods we
marked expression values to be missing when the corre-
sponding continuous weight was less than 0.5. In this way
β defined a cutoff for when a value is considered to be
missing.
To cross check that the findings in this paper do not
depend on SNR, we also used a simple weight based on
intensity only:
This weight is also bound to be within zero and unity, and
β has the same function here as for the SNR based weight
above.
Imputation methods
We compared five imputation methods; three non-weight
based methods, reporter average, KNNimpute, and
LSimpute_adaptive; and two weight based, weighted
reporter average and weighted nearest neighbours impu-
tation (WeNNI).
Reporter average methods
The widely used reporter average imputation method is
intuitive and easy to implement. Assuming the expression
level of a reporter in one experiment to be similar to the
expression level in other experiments the expression value
is imputed as the average of the reporter's expression value
over all experiments. Similarly to Andersson et al. [21], we
extended the reporter average by using continuous spot
quality weights between zero and unity. A spot with a
weight equal to unity is not imputed, whereas for a spot
with weight equal to zero the expression value is imputed
to be the weighted reporter average. A spot having an
intermediate weight is imputed as a linear combination of
the extreme cases above. These three cases are covered in
the imputation equation
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 = wrexre + (1 - wre),    ( 5 )
in which xre is the expression value in reporter r and exper-
iment e, wre is the quality weight, and   is the weighted
reporter average
where M is the number of experiments.
The use of the spot quality weight is twofold. First, the
weight is used in the calculation of the reporter average.
Second, the weight is used in the calculation of the
imputed expression value – poor quality spots are
changed more than good quality spots.
KNNimpute
The currently most popular imputation method that goes
beyond reporter averaging. KNNimpute, has been shown
to be a very good method for imputation of missing val-
ues [12]. The main idea of KNNimpute is to look for the
K most similar reporters when a value is missing for a
reporter. Two reporters n and m are considered to be sim-
ilar when the Euclidean distance.
between their expression patterns is small. These K report-
ers are used to calculate a weighted average of the values
in the experiment of interest. The weighted average is cal-
culated as
where xie is the value of the ith nearest reporter, dri is the
distance between reporter r and reporter i and K is the
number of neighbours to use in the calculation. This
weighted average is used as imputation value of missing
values.
Weighted Nearest Neighbours Imputation [WeNNI]
KNNimpute is binary in the sense that each value is
regarded as either missing or present. In WeNNI, we
smooth out this sharp border between missing and
present values by assigning a continuous quality weight to
each value, where a zero weight means the value is com-
pletely missing and a larger weight means the value is
more reliable. In the special case when all weights are
either 0 or 1. WeNNI is equivalent to KNNimpute.
The WeNNI method consists of two steps. First, we calcu-
late distances between the reporters taking the weights
into account. Second, we calculate a weighted average of
the values of the nearest neighbours. We expanded the
Euclidean distance used in KNNimpute to include quality
weights. The weights were included in such a way that
spots with large weights are more important for the dis-
tance measure than spots with low weights. We calculated
the distance dnm between reporter n and reporter m as
where M is the number of experiments. A weighted aver-
age of the nearest neighbours is calculated as
where L is defined by
In the second step, we take the imputed value as a linear
combination of the original value and the value suggested
by the neighbours
 = wrexre + (1 - wre) .   (12)
As for weighted reporter average above, when the quality
weight is zero, we ignore the original value. When the
weight is unity, we trust the original value and ignore the
value suggested by the neighbours.
LSimpute
Bø et al. showed that LSimpute_adaptive is a very good
method for imputation of missing values [17]. The
method is based on the least squares principle, which
means the sum of squared errors of a regression model is
minimised and the regression model is used to impute
missing values. The method utilises correlations both
between reporters and experiments.
In the comparisons made in this report, we used the
LSimpute_adaptive algorithm implemented in the pub-
licly available LSimpute program [17].
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Evaluation method
In order to validate the imputation methods we did as fol-
lows for each of the three data sets. We split the data into
replicate data sets: two sets for the melanoma and breast
cancer data, and four sets for the mycorrhiza data. We
imputed the data in one of the replicate data sets and com-
pared the imputed data, x', to the other pristine replicate
data,  y. For the mycorrhiza data, we compared the
imputed data to the (non-weighted) average of the three
pristine replicate data sets. We measured the quality of the
method using the mean squared deviation
where the sum runs over all expression values in all repli-
cate data sets, except spots in the pristine data set that were
marked as invalid in the data pre-processing step
described above. The fraction of spots not used in the
summation were: 6% for the melanoma data, 7% for the
breast cancer data, and 8% for the mycorrhiza data.
The motivation for this choice of MSD as evaluation met-
ric is threefold. First, in the weighted methods the
imputed value is a linear combination of the value sug-
gested by the neighbours and the original value. Hence,
comparing with the original value would introduce an
information leak, making the evaluation unfair. Second,
introducing artificial missing values randomly may not be
optimal [15,25], since it assumes missing values to occur
uncorrelated. By using replicates we could avoid this
problem and mark spots as missing values depending on
their quality. Third, we avoided any bias that could be
introduced by imputing both replicates and comparing
the imputed values. By considering the zero impute
method (missing values are set to zero), it is easy to under-
stand that a bias could be introduced. If both replicate
spots are imputed, i.e., both set to zero, they would have
no deviation and the evaluation would obviously be flat-
tering.
Availability and requirements
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